Skip to main content
Erschienen in: Pediatric Nephrology 11/2004

01.11.2004 | Original Article

Effects of advanced glycosylation endproducts on perlecan core protein of glomerular epithelium

verfasst von: Tae-Sun Ha, Chang-Ju Song, Joon-Ho Lee

Erschienen in: Pediatric Nephrology | Ausgabe 11/2004

Einloggen, um Zugang zu erhalten

Abstract

Perlecan is one of major heparan sulfate proteoglycans in the glomerular basement membrane and is reduced in the renal parenchyma of diabetic patients and animals with proteinuria. To examine the effects of glucose and advanced glycosylated end-products (AGE) on perlecan, we cultured rat glomerular epithelial cells (GEpC) on AGE- or bovine serum albumin (BSA)-coated plates under normal (NG, 5 mM) and high-glucose (HG, 30 mM) conditions and measured the change in perlecan core protein production by a sandwich ELISA and northern blot analysis. We observed significant decreases of perlecan core protein under HG conditions at 1 week incubation, specifically on the AGE-coated compared with the BSA-coated surface, by 22.2% and 4.7%, respectively. The expression of mRNA for perlecan promoter was decreased under HG conditions on AGE-coated surfaces by 19.7% at 2 days and 61.1% at 1 week. Even under NG condition, the expression of mRNA was reduced by 30% at 1 week if GEpC were grown on an AGE-coated surface. In conclusion, HG and AGE have an additive effect in reducing the production of perlecan core protein by GEpC in vitro. AGE had a greater effect than HG, implying that the inhibition of AGE formation may be more effective than short-term glucose control in the prevention of diabetic proteinuria.
Literatur
1.
Zurück zum Zitat Parving H-H, Osterby R, Anderson PW, Hsueh WA (1996) Diabetic nephropathy. In: Brenner BM (ed) Brenner and Rector’s the kidney. Saunders, Philadelphia, pp 1864–1892 Parving H-H, Osterby R, Anderson PW, Hsueh WA (1996) Diabetic nephropathy. In: Brenner BM (ed) Brenner and Rector’s the kidney. Saunders, Philadelphia, pp 1864–1892
2.
Zurück zum Zitat Sharma K, Ziyadeh FN (1997) Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin Nephrol 17:80–92PubMed Sharma K, Ziyadeh FN (1997) Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin Nephrol 17:80–92PubMed
3.
Zurück zum Zitat Vlassara H (1996) Protein glycation in the kidney: role in diabetes and aging. Kidney Int 49:1795–1804PubMed Vlassara H (1996) Protein glycation in the kidney: role in diabetes and aging. Kidney Int 49:1795–1804PubMed
4.
Zurück zum Zitat Tamsma JT, Van den Born J, Bruijn JA, Assmann KJM, Weening JJ, Berden JHM, Wieslander J, Schrama E, Hermans J, Veerkamp JH, Lemkes HHPJ, Van der Woude FJ (1994) Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37:313–320CrossRefPubMed Tamsma JT, Van den Born J, Bruijn JA, Assmann KJM, Weening JJ, Berden JHM, Wieslander J, Schrama E, Hermans J, Veerkamp JH, Lemkes HHPJ, Van der Woude FJ (1994) Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37:313–320CrossRefPubMed
5.
Zurück zum Zitat Kreisberg JI, Hoover RL, Karnovsky MJ (1978) Isolation and characterization of rat glomerular epithelial cells in vitro. Kidney Int 14:21–30PubMed Kreisberg JI, Hoover RL, Karnovsky MJ (1978) Isolation and characterization of rat glomerular epithelial cells in vitro. Kidney Int 14:21–30PubMed
6.
Zurück zum Zitat Singh AK, Mo WA, Dunea G, Arruda JAL (1997) Effect of glycated proteins on the matrix of glomerular epithelial cells. J Am Soc Nephrol 9:802–810 Singh AK, Mo WA, Dunea G, Arruda JAL (1997) Effect of glycated proteins on the matrix of glomerular epithelial cells. J Am Soc Nephrol 9:802–810
7.
Zurück zum Zitat Pegoraro AA, Singh AK, Arruda JAL, Dunea G, Bakir AA (2000) A simple method to detect an albumin permeability factor in the idiopathic nephrotic syndrome. Kidney Int 58:1342–1345CrossRefPubMed Pegoraro AA, Singh AK, Arruda JAL, Dunea G, Bakir AA (2000) A simple method to detect an albumin permeability factor in the idiopathic nephrotic syndrome. Kidney Int 58:1342–1345CrossRefPubMed
8.
Zurück zum Zitat Kasinath BS, Grellier P, Terhune WC, Ghosh-Choudhury G, Maldonado R, Abboud S (1996) Regulation of basement membrane heparan sulfate proteoglycan core protein gene expression by high glucose medium in glomerular epithelial cells. J Cell Physiol 167:131–136CrossRefPubMed Kasinath BS, Grellier P, Terhune WC, Ghosh-Choudhury G, Maldonado R, Abboud S (1996) Regulation of basement membrane heparan sulfate proteoglycan core protein gene expression by high glucose medium in glomerular epithelial cells. J Cell Physiol 167:131–136CrossRefPubMed
9.
Zurück zum Zitat Ziyadeh FN (1993) The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22:736–744PubMed Ziyadeh FN (1993) The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22:736–744PubMed
10.
Zurück zum Zitat Parthasarathy N, Spiro RG (1982) Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes 31:738–741PubMed Parthasarathy N, Spiro RG (1982) Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes 31:738–741PubMed
11.
Zurück zum Zitat Shimomura H, Spiro RG (1987) Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes: decreased levels of heparan sulfate proteoglycan and laminin. Diabetes 36:374–381PubMed Shimomura H, Spiro RG (1987) Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes: decreased levels of heparan sulfate proteoglycan and laminin. Diabetes 36:374–381PubMed
12.
Zurück zum Zitat Makino H, Yamasaki Y, Haramoto T, Shikata K, Hironaka K, Ota Z, Kanwar YS (1993) Ultrastructural changes of extracellular matrices in diabetic nephropathy revealed by high resolution scanning and immunoelectron microscopy. Lab Invest 68:45–55PubMed Makino H, Yamasaki Y, Haramoto T, Shikata K, Hironaka K, Ota Z, Kanwar YS (1993) Ultrastructural changes of extracellular matrices in diabetic nephropathy revealed by high resolution scanning and immunoelectron microscopy. Lab Invest 68:45–55PubMed
13.
Zurück zum Zitat Van den Born J, Van den Heuvel LPWJ, Bakker MAH, Veerkamp JH, Assmann KJM, Weening JJ, Berden JHM (1993) Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kindey Int 43:454–463 Van den Born J, Van den Heuvel LPWJ, Bakker MAH, Veerkamp JH, Assmann KJM, Weening JJ, Berden JHM (1993) Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kindey Int 43:454–463
14.
Zurück zum Zitat Nerlich A, Schleicher E (1991) Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 139:889–899PubMed Nerlich A, Schleicher E (1991) Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 139:889–899PubMed
15.
Zurück zum Zitat Makino H, Ikeda S, Haramoto T, Ota Z (1992) Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy. Nephron 61:415–421PubMed Makino H, Ikeda S, Haramoto T, Ota Z (1992) Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy. Nephron 61:415–421PubMed
16.
Zurück zum Zitat Van den Born J, Van Kraats AA, Bakker MA, Assmann KJ, Van den Heuvel LP, Veerkamp JH, Berden JH (1995) Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate. Diabetologia 38:161–172CrossRefPubMed Van den Born J, Van Kraats AA, Bakker MA, Assmann KJ, Van den Heuvel LP, Veerkamp JH, Berden JH (1995) Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate. Diabetologia 38:161–172CrossRefPubMed
17.
Zurück zum Zitat Karasawa R, Nishi S, Suzuki Y, Imai N, Arakawa M (1997) Early increase of chondroitin sulfate glycosaminoglycan in the glomerular basement membrane of rats with diabetic glomerulopathy. Nephron 76:62–71PubMed Karasawa R, Nishi S, Suzuki Y, Imai N, Arakawa M (1997) Early increase of chondroitin sulfate glycosaminoglycan in the glomerular basement membrane of rats with diabetic glomerulopathy. Nephron 76:62–71PubMed
18.
Zurück zum Zitat Fukui M, Nakamura T, Ebihara L Shirato I, Tomino Y, Koide H (1992) ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41:1520–1527PubMed Fukui M, Nakamura T, Ebihara L Shirato I, Tomino Y, Koide H (1992) ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41:1520–1527PubMed
19.
Zurück zum Zitat Kofoed-Enevoldsen A, Noonan D, Deckert T (1993) Diabetes mellitus induced inhibition of glucosaminyl N -deacetylase: effect of short-term blood glucose control in diabetic rats. Diabetologia 36:310–315PubMed Kofoed-Enevoldsen A, Noonan D, Deckert T (1993) Diabetes mellitus induced inhibition of glucosaminyl N -deacetylase: effect of short-term blood glucose control in diabetic rats. Diabetologia 36:310–315PubMed
20.
Zurück zum Zitat Ledbetter S, Copeland EJ, Noonan D, Vogeli G, Hassell JR (1990) Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Diabetes 39:196–203PubMed Ledbetter S, Copeland EJ, Noonan D, Vogeli G, Hassell JR (1990) Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Diabetes 39:196–203PubMed
21.
Zurück zum Zitat Van Det NF, Van den Born J, Tamsma JT, Verhagen NAM, Berden JHM, Bruijn JA, Daha MR, Van der Woude FJ (1996) Effects of high glucose on the production of heparan sulphate proteoglycan by human mesangial and glomerular visceral epithelial cells in vitro. Kidney Int 49:1079–1089PubMed Van Det NF, Van den Born J, Tamsma JT, Verhagen NAM, Berden JHM, Bruijn JA, Daha MR, Van der Woude FJ (1996) Effects of high glucose on the production of heparan sulphate proteoglycan by human mesangial and glomerular visceral epithelial cells in vitro. Kidney Int 49:1079–1089PubMed
22.
Zurück zum Zitat Van Det NF, Verhagen NAM, Tamsma JT, Berden JHM, Bruijn JA, Daha MR (1997) Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-β by high glucose, not by angiotensin II. Diabetes 46:834–840PubMed Van Det NF, Verhagen NAM, Tamsma JT, Berden JHM, Bruijn JA, Daha MR (1997) Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-β by high glucose, not by angiotensin II. Diabetes 46:834–840PubMed
23.
Zurück zum Zitat Ha T-S, Duraisamy S, Faulkner JL, Kasinath BS (2004) Regulation of glomerular endothelial cell proteoglycans by glucose. J Korean Med Sci 19:245–252PubMed Ha T-S, Duraisamy S, Faulkner JL, Kasinath BS (2004) Regulation of glomerular endothelial cell proteoglycans by glucose. J Korean Med Sci 19:245–252PubMed
24.
Zurück zum Zitat Raats CJ, Van den Born J, Berden JH (2000) Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria. Kidney Int. 57:385–400 Raats CJ, Van den Born J, Berden JH (2000) Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria. Kidney Int. 57:385–400
25.
Zurück zum Zitat Iozzo RV, Cohen IR, Grassel S, Murdoch AD (1994) The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem J. 302:625–639 Iozzo RV, Cohen IR, Grassel S, Murdoch AD (1994) The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem J. 302:625–639
26.
Zurück zum Zitat Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315–1321PubMed Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315–1321PubMed
27.
Zurück zum Zitat Vlassara H, Bucala R, Striker L (1994) Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70:138–151PubMed Vlassara H, Bucala R, Striker L (1994) Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70:138–151PubMed
28.
Zurück zum Zitat Makino H, Shikata K, Kushiro M, Hironaka K, Yamasaki Y, Sugimoto H, Ota Z, Araki N, Horiuchi S (1996) Roles of advanced glycation end-products in the progression of diabetic nephropathy. Nephrol Dial Transplant 11 [Suppl 5]:76–80 Makino H, Shikata K, Kushiro M, Hironaka K, Yamasaki Y, Sugimoto H, Ota Z, Araki N, Horiuchi S (1996) Roles of advanced glycation end-products in the progression of diabetic nephropathy. Nephrol Dial Transplant 11 [Suppl 5]:76–80
29.
Zurück zum Zitat Yang CW, Vlassara H, Peten EP, He CJ, Striker GE, Striker LJ (1994) Advanced glycosylation endproducts up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci U S A 91:9136–9140PubMed Yang CW, Vlassara H, Peten EP, He CJ, Striker GE, Striker LJ (1994) Advanced glycosylation endproducts up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci U S A 91:9136–9140PubMed
30.
Zurück zum Zitat Striker LJ, Striker GE (1996) Administration of AGEs in vivo induces extracellular matrix gene expression. Nephrol Dial Transplant 11 [Suppl 5]:62–65 Striker LJ, Striker GE (1996) Administration of AGEs in vivo induces extracellular matrix gene expression. Nephrol Dial Transplant 11 [Suppl 5]:62–65
31.
Zurück zum Zitat Ha T-S, Barnes JL, Stewart JL, Ko CW, Miner JH, Abrahamson DR, Sanes JR, Kasinath BS (1999) Regulation of renal laminin in mice with type II diabetes. J Am Soc Nephrol 10:1931–1939 Ha T-S, Barnes JL, Stewart JL, Ko CW, Miner JH, Abrahamson DR, Sanes JR, Kasinath BS (1999) Regulation of renal laminin in mice with type II diabetes. J Am Soc Nephrol 10:1931–1939
Metadaten
Titel
Effects of advanced glycosylation endproducts on perlecan core protein of glomerular epithelium
verfasst von
Tae-Sun Ha
Chang-Ju Song
Joon-Ho Lee
Publikationsdatum
01.11.2004
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 11/2004
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-004-1590-1

Weitere Artikel der Ausgabe 11/2004

Pediatric Nephrology 11/2004 Zur Ausgabe

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Reanimation bei Kindern – besser vor Ort oder während Transport?

29.05.2024 Reanimation im Kindesalter Nachrichten

Zwar scheint es laut einer Studie aus den USA und Kanada bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.